Infliximab: A promising new treatment option for ulcerated necrobiosis lipoidica [2]

Dermatology

Volumn 206, Issue 2, 2003, Pages 180-181

  Kolde, Gerhard ^a   Muche, J Marcus ^a   Schulze, Peter ^a   Fischer, Peter ^b   Lichey, Jürgen ^b  

^a HUMBOLDT UNIVERSITY   (Germany)

^b Department of Pneumology   (Germany)

Author keywords

Infliximab; Miliary tuberculosis; Necrobiosis lipoidica; Tumor necrosis factor antibody

Indexed keywords

CORTICOSTEROID; CYCLOSPORIN; INFLIXIMAB;

ADULT; CASE REPORT; CLINICAL FEATURE; COUGHING; DRUG TOLERABILITY; DYSPNEA; FEVER; GENERAL CONDITION IMPROVEMENT; HUMAN; HUMAN TISSUE; INSULIN DEPENDENT DIABETES MELLITUS; LETTER; LYMPH NODE BIOPSY; MALE; MILIARY TUBERCULOSIS; MUSCLE WEAKNESS; NECROBIOSIS LIPOIDICA; NIGHT SWEAT; PHOTOCHEMOTHERAPY; PRIORITY JOURNAL; SIDE EFFECT; WEIGHT REDUCTION;

ADULT; ANTIBODIES, MONOCLONAL; DERMATOLOGIC AGENTS; HUMANS; LEG ULCER; MALE; NECROBIOSIS LIPOIDICA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0037272502     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000068465     Document Type: Letter

References (9)

1. Chaudhari U, Romano P, Mulcahy LD, Dooley LT, Baker DG, Gottlieb AB: Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: A randomised trial. Lancet 2001;357:1842-1847.
2. Tan MH, Gordon M, Lebwohl O, George J, Lebwohl MG: Improvement of pyoderma gangrenosum and psoriasis associated with Crohn disease with anti-tumor necrosis factor alpha monoclonal antibody. Arch Dermatol 2001;137:930-933.
3. Voigtlander C, Luftl M, Schuler G, Hertl M: Infliximab (anti-tumor necrosis factor alpha antibody): A novel, highly effective treatment of recalcitrant subcorneal pustular dermatosis (Sneddon-Wilkinson disease). Arch Dermatol 2001;137:1571-1574.
4. Yee AM, Pochapin MB: Treatment of complicated sarcoidosis with infliximab anti-tumor necrosis factor-alpha therapy. Ann Intern Med 2001;135:27-31.
5. Muller SA, Winkelmann RK: Necrobiosis lipoidica diabeticorum: A clinical and pathological investigation of 171 cases. Arch Dermatol 1966;93:272-281.
6. Lowitt MH, Dover JS: Necrobiosis lipoidica. J Am Acad Dermatol 1991;25:735-748.
7. Nguyen K, Washenik K, Shupack J: Necrobiosis lipoidica diabeticorum treated with chloroquine. J Am Acad Dermatol 2002;46:S34-S36.
8. Kim SJ, Hong YP, Lew WJ, Yang SC, Lee EG: Incidence of pulmonary tuberculosis among diabetics. Tuberc Lung Dis 1995;76:529-533.
9. Keane J, Gershon S, Wise RP, Mirabile-Levens E, Kasznica J, Schwieterman WD, Siegel JN, Braun M: Tuberculosis associated with infliximab, a tumor necrosis factor α-neutralizing agent. N Engl J Med 2001;345:1098-1104.